0 Views
0 Likes
0 Shares
0 Comments
Read article ↗

StayCurrentMD

View profile →

Article

Exploratory Assessment of Levosimendan in Infants With Congenital Diaphragmatic Hernia

Published: Reading: 1 min

Topic overview

Retrospective study of 24 infants with congenital diaphragmatic hernia treated with levosimendan showed improvement in pulmonary hypertension and biventricular dysfunction within 7 days. The inodilator was associated with reduced ventilatory support needs and vasoactive medication requirements, with minimal adverse effects.

Keywords

Congenital Diaphragmatic Hernia Levosimendan Pulmonary Hypertension Neonatal Critical Care Right Ventricular Dysfunction Ecmo Support

Hashtags

#CongenitalDiaphragmaticHernia #NeonatalCriticalCare #PulmonaryHypertension #Levosimendan

Full article text

Full article text not available for this entry
How to cite: GlobalCastMD. Exploratory Assessment of Levosimendan in Infants With Congenital Diaphragmatic Hernia. GlobalCastMD Medical Library. 2021-04-18. https://library.globalcastmd.com/article/3953

Comments

Loading comments...